Literature DB >> 1310705

Expression of insulin-like growth factor II (IGF-II) and IGF-II, IGF-I and insulin receptors mRNAs in isolated non-parenchymal rat liver cells.

F Zindy1, E Lamas, S Schmidt, A Kirn, C Brechot.   

Abstract

The insulin-like growth factor II (IGF-II) is involved in embryonic growth. Modifications of its expression might play a role in the development of primary liver cancer in humans and woodchucks. In the liver, little information is available on the cell types involved in its synthesis. We have investigated the expression of IGF-II as well as IGF-II, IGF-I and insulin receptor mRNAs in non parenchymal liver cell preparations in rats of various ages. The results indicate that Kupffer cells, endothelial cells and fat-storing cells express both IGF-II and the three different receptor mRNAs. Furthermore, a switch from a fetal to an adult IGF-II mRNA profile was obtained in the different cell preparations. Therefore, our results indicate that regulation of IGF-II gene expression can be analyzed through these isolated liver cell preparations. These results might also be important in investigating the potential role of IGF-II in liver carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310705     DOI: 10.1016/0168-8278(92)90127-b

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

Authors:  S Sanz; J B Pucilowska; S Liu; C M Rodríguez-Ortigosa; P K Lund; D A Brenner; C R Fuller; J G Simmons; A Pardo; M-L Martínez-Chantar; J A Fagin; J Prieto
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

2.  Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C.

Authors:  Jose Tadeu Stefano; Maria Lucia Correa-Giannella; Cristiane Maria Freitas Ribeiro; Venancio Avancini Ferreira Alves; Paulo Celso Bosco Massarollo; Marcel Cerqueira Cesar Machado; Daniel Giannella-Neto
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  A fresh look at augmenter of liver regeneration in rats.

Authors:  C R Gandhi; R Kuddus; V M Subbotin; J Prelich; N Murase; A S Rao; M A Nalesnik; S C Watkins; A DeLeo; M Trucco; T E Starzl
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

Review 4.  The IGF axis and hepatocarcinogenesis.

Authors:  J G Scharf; F Dombrowski; G Ramadori
Journal:  Mol Pathol       Date:  2001-06

5.  Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis.

Authors:  Nolann G Williams; Jillian P Interlichia; Melissa F Jackson; David Hwang; Pinchas Cohen; Buel D Rodgers
Journal:  Endocrinology       Date:  2010-12-08       Impact factor: 4.736

Review 6.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

Review 7.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 8.  Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key.

Authors:  Meena B Bansal
Journal:  Hepatol Int       Date:  2016-08-30       Impact factor: 6.047

9.  An in vitro model for hepatocyte-like cell differentiation from Wharton's jelly derived-mesenchymal stem cells by cell-base aggregates.

Authors:  Tahereh Talaei-Khozani; Maryam Borhani-Haghighi; Maryam Ayatollahi; Zahra Vojdani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

Review 10.  The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.

Authors:  Claudia Pivonello; Maria Cristina De Martino; Mariarosaria Negri; Gaia Cuomo; Federica Cariati; Francesco Izzo; Annamaria Colao; Rosario Pivonello
Journal:  Infect Agent Cancer       Date:  2014-08-20       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.